ASX
Paradigm Biopharmaceuticals
PAR:ASX•Healthcare
Sensitive ASX Announcement
PAR RECEIVES POSITIVE RESPONSE FROM US FDA FOR PHASE 3
Published: 18/09/24, 08:40am (AEST)•3 pages